GLS and colorectal cancer: In colorectal cancer, up-regulated YTHDF1 decreases the cisplatin sensitivity of cancer cells by increasing the translation of glutaminase GLS1, and inhibition of GLS1 increases the therapeutic effect of cisplatin.113